Demographic, Payer, and Clinical Characteristics of Patients Receiving Bevacizumab (BEV) And Ranibizumab (RAN) For Treatment of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)

May 1, 2018, 00:00
10.1016/j.jval.2018.04.1641
https://www.valueinhealthjournal.com/article/S1098-3015(18)31963-6/fulltext
Title : Demographic, Payer, and Clinical Characteristics of Patients Receiving Bevacizumab (BEV) And Ranibizumab (RAN) For Treatment of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31963-6&doi=10.1016/j.jval.2018.04.1641
First page :
Section Title :
Open access? : No
Section Order : 871
Categories :
Tags :
Regions :
ViH Article Tags :